Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric C Klawiter, M.D.

Title
Institution
Department
Address
Phone
Fax

Overview
Dr. Klawiter's research interests include multiple sclerosis clinical research and developing new imaging techniques to better understand, diagnose and treat multiple sclerosis.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K23NS078044 (KLAWITER, ERIC) Apr 1, 2012 - Mar 31, 2017
    NIH/NINDS
    Disconnection as a model for cognitive dysfunction in multiple sclerosis
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Barletta VT, Herranz E, Treaba CA, Ouellette R, Mehndiratta A, Loggia M, Klawiter EC, Ionete C, Jacob SA, Mainero C. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET. Mult Scler. 2019 Apr 11; 1352458519843048. PMID: 30973800.
    Citations:    
  2. Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. 2019 Mar 12; 92(11):519-533. PMID: 30787160.
    Citations:    
  3. Fan Q, Tian Q, Ohringer NA, Nummenmaa A, Witzel T, Tobyne SM, Klawiter EC, Mekkaoui C, Rosen BR, Wald LL, Salat DH, Huang SY. Age-related alterations in axonal microstructure in the corpus callosum measured by high-gradient diffusion MRI. Neuroimage. 2019 May 01; 191:325-336. PMID: 30790671.
    Citations:    
  4. Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A. Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. N Engl J Med. 2018 08 30; 379(9):846-855. PMID: 30157388.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  5. Patel KR, Tobyne S, Porter D, Bireley JD, Smith V, Klawiter E. Structural disconnection is responsible for increased functional connectivity in multiple sclerosis. Brain Struct Funct. 2018 Jun; 223(5):2519-2526. PMID: 29453522.
    Citations: 1     Fields:    
  6. Smith VM, Varsanik JS, Walker RA, Russo AW, Patel KR, Gabel W, Phillips GA, Kimmel ZM, Klawiter EC. Movement measurements at home for multiple sclerosis: walking speed measured by a novel ambient measurement system. Mult Scler J Exp Transl Clin. 2018 Jan-Mar; 4(1):2055217317753465. PMID: 29383266.
    Citations:    
  7. Granberg T, Fan Q, Treaba CA, Ouellette R, Herranz E, Mangeat G, Louapre C, Cohen-Adad J, Klawiter EC, Sloane JA, Mainero C. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis. Brain. 2017 Nov 01; 140(11):2912-2926. PMID: 29053798.
    Citations: 2     Fields:    Translation:HumansCells
  8. Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, Paul F, Cross AH, Jacobs A, Chitnis T, Weinshenker B. High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology. 2017 Nov 28; 89(22):2238-2244. PMID: 29093070.
    Citations: 2     Fields:    Translation:Humans
  9. Duval T, Smith V, Stikov N, Klawiter EC, Cohen-Adad J. Scan-rescan of axcaliber, macromolecular tissue volume, and g-ratio in the spinal cord. Magn Reson Med. 2018 05; 79(5):2759-2765. PMID: 28994487.
    Citations:    Fields:    
  10. Tobyne SM, Ochoa WB, Bireley JD, Smith VM, Geurts JJ, Schmahmann JD, Klawiter EC. Cognitive impairment and the regional distribution of cerebellar lesions in multiple sclerosis. Mult Scler. 2018 Nov; 24(13):1687-1695. PMID: 28933672.
    Citations:    Fields:    
  11. Bove R, Elsone L, Alvarez E, Borisow N, Cortez MM, Mateen FJ, Mealy MA, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cross AH, Weinshenker B, Jacob A, Klawiter EC, Chitnis T. Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e339. PMID: 28382320.
    Citations: 7     
  12. Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016 12; 12(12):714-722. PMID: 27834394.
    Citations: 16     Fields:    Translation:Humans
  13. Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol. 2016 Nov; 80(5):776-790. PMID: 27686563.
    Citations: 15     Fields:    Translation:Humans
  14. Duval T, Le Vy S, Stikov N, Campbell J, Mezer A, Witzel T, Keil B, Smith V, Wald LL, Klawiter E, Cohen-Adad J. g-Ratio weighted imaging of the human spinal cord in vivo. Neuroimage. 2017 01 15; 145(Pt A):11-23. PMID: 27664830.
    Citations: 9     Fields:    Translation:HumansCells
  15. Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, Weinstock-Gutman B, Yadav V, Zabeti A. Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis. Contemp Clin Trials. 2016 09; 50:166-77. PMID: 27521810.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  16. Tobyne SM, Boratyn D, Johnson JA, Greve DN, Mainero C, Klawiter EC. A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application. Hum Brain Mapp. 2016 08; 37(8):2849-68. PMID: 27219660.
    Citations:    Fields:    Translation:Humans
  17. Huang SY, Tobyne SM, Nummenmaa A, Witzel T, Wald LL, McNab JA, Klawiter EC. Characterization of Axonal Disease in Patients with Multiple Sclerosis Using High-Gradient-Diffusion MR Imaging. Radiology. 2016 07; 280(1):244-51. PMID: 26859256.
    Citations: 2     Fields:    Translation:HumansCells
  18. Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S. Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e134. PMID: 26236760.
    Citations: 16     
  19. Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2015 Jul; 72(7):815-22. PMID: 26010909.
    Citations: 12     Fields:    Translation:Humans
  20. Duval T, McNab JA, Setsompop K, Witzel T, Schneider T, Huang SY, Keil B, Klawiter EC, Wald LL, Cohen-Adad J. In vivo mapping of human spinal cord microstructure at 300mT/m. Neuroimage. 2015 Sep; 118:494-507. PMID: 26095093.
    Citations: 9     Fields:    Translation:Humans
  21. Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, Banwell BL, Villoslada P, Saiz A, Fujihara K, Kim SH. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015 Mar 17; 84(11):1165-73. PMID: 25695963.
    Citations: 49     Fields:    Translation:HumansAnimals
  22. Klawiter EC, Ceccarelli A, Arora A, Jackson J, Bakshi S, Kim G, Miller J, Tauhid S, von Gizycki C, Bakshi R, Neema M. Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis. J Neuroimaging. 2015 Jan-Feb; 25(1):62-7. PMID: 24816394.
    Citations: 4     Fields:    Translation:Humans
  23. Klawiter EC. Current and new directions in MRI in multiple sclerosis. Continuum (Minneap Minn). 2013 Aug; 19(4 Multiple Sclerosis):1058-73. PMID: 23917101.
    Citations: 5     Fields:    Translation:Humans
  24. Naismith RT, Xu J, Klawiter EC, Lancia S, Tutlam NT, Wagner JM, Qian P, Trinkaus K, Song SK, Cross AH. Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology. 2013 Jun 11; 80(24):2201-9. PMID: 23667060.
    Citations: 22     Fields:    Translation:Humans
  25. Alvarez E, Piccio L, Mikesell RJ, Klawiter EC, Parks BJ, Naismith RT, Cross AH. CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions. Mult Scler. 2013 Aug; 19(9):1204-8. PMID: 23322500.
    Citations: 18     Fields:    Translation:Humans
  26. Xu J, Shimony JS, Klawiter EC, Snyder AZ, Trinkaus K, Naismith RT, Benzinger TL, Cross AH, Song SK. Improved in vivo diffusion tensor imaging of human cervical spinal cord. Neuroimage. 2013 Feb 15; 67:64-76. PMID: 23178538.
    Citations: 17     Fields:    Translation:HumansCells
  27. Qian P, Lancia S, Alvarez E, Klawiter EC, Cross AH, Naismith RT. Association of neuromyelitis optica with severe and intractable pain. Arch Neurol. 2012 Nov; 69(11):1482-7. PMID: 22926050.
    Citations: 12     Fields:    Translation:Humans
  28. Klawiter EC, Xu J, Naismith RT, Benzinger TL, Shimony JS, Lancia S, Snyder AZ, Trinkaus K, Song SK, Cross AH. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Mult Scler. 2012 Sep; 18(9):1259-68. PMID: 22354742.
    Citations: 16     Fields:    Translation:Humans
  29. Virmani T, Agarwal A, Klawiter EC. Clinical reasoning: A young adult presents with focal weakness and hemorrhagic brain lesions. Neurology. 2011 May 31; 76(22):e106-9. PMID: 21624981.
    Citations: 1     Fields:    Translation:Humans
  30. Klawiter EC, Schmidt RE, Trinkaus K, Liang HF, Budde MD, Naismith RT, Song SK, Cross AH, Benzinger TL. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage. 2011 Apr 15; 55(4):1454-60. PMID: 21238597.
    Citations: 95     Fields:    Translation:HumansCells
  31. Klawiter EC, Benzinger T, Roy A, Naismith RT, Parks BJ, Cross AH. Spinal cord ring enhancement in multiple sclerosis. Arch Neurol. 2010 Nov; 67(11):1395-8. PMID: 21060017.
    Citations: 5     Fields:    Translation:Humans
  32. Klawiter EC, Piccio L, Lyons JA, Mikesell R, O'Connor KC, Cross AH. Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Arch Neurol. 2010 Sep; 67(9):1102-8. PMID: 20837855.
    Citations: 10     Fields:    Translation:Humans
  33. Klawiter EC, Cross AH, Naismith RT. The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%? Neurology. 2009 Sep 22; 73(12):984-90. PMID: 19770475.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  34. Naismith RT, Tutlam NT, Xu J, Shepherd JB, Klawiter EC, Song SK, Cross AH. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology. 2009 Jul 07; 73(1):46-52. PMID: 19564583.
    Citations: 36     Fields:    Translation:HumansCells
  35. Klawiter EC, Alvarez E, Xu J, Paciorkowski AR, Zhu L, Parks BJ, Cross AH, Naismith RT. NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology. 2009 Mar 24; 72(12):1101-3. PMID: 19307546.
    Citations: 18     Fields:    Translation:Humans
  36. Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 2009 Mar 24; 72(12):1077-82. PMID: 19307541.
    Citations: 55     Fields:    Translation:HumansCells
  37. Klawiter EC, Cross AH. B cells: no longer the nondominant arm of multiple sclerosis. Curr Neurol Neurosci Rep. 2007 May; 7(3):231-8. PMID: 17488589.
    Citations: 6     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Klawiter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (123)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.